everolimus - Robuta Search

https://adisinsight.springer.com/trials/700265156?error=cookies_not_supported&code=844de823-e29c-4686-9e99-32f98cacbede A study of Everolimus eluting ABSORB Bioresorbable vascular scaffold (BVS) for treatment of... This study demonstrated the safety of Everolimus eluting ABSORB Bioresorbable vascular scaffold (BVS) for the treatment of Coronary Bifurcation lesions. a study https://adisinsight.springer.com/drugsafety/803373061?error=cookies_not_supported&code=e59bcb5a-2d10-43e0-b5b2-1f521ba218fb Everolimus - AdisInsight In a single-centre observational prospective study of six patients conducted from December 2016 to March 2018, an infant [exact age at reaction onset and sex everolimus adisinsight https://researchconnect.buffalo.edu/en/publications/everolimus-versus-sunitinib-for-patients-with-metastatic-non-clea/ Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma... for patients https://www.medlineplus.gov/druginfo/meds/a609032.html Everolimus: MedlinePlus Drug Information Everolimus: learn about side effects, dosage, special precautions, and more on MedlinePlus everolimus medlineplus drug information https://myhealth.alberta.ca/health/medications/Pages/conditions.aspx?hwid=fdb1191 Everolimus - Oral everolimus oral https://health.economictimes.indiatimes.com/news/industry/verolimus-eluting-stent-stands-superior-to-other-stents-for-treatment-of-diabetic-patients-in-india-dr-ashok-seth/74503419 Everolimus-Eluting Stent stands superior to other stents for treatment of diabetic patients in... Nearly 40-45 per cent of patients who undergo angioplasty in our country or bypass are diabetics. It has been clearly demonstrated that diabetics have a higher... https://www.sciencedaily.com/releases/2016/06/160629125833.htm Everolimus R-CHOP combination safe for treating diffuse large B-cell lymphoma | ScienceDaily The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study.... https://oa-fund.ub.uni-muenchen.de/id/eprint/173/ Effect of Sirolimus vs. Everolimus on CMV-Infections after Kidney Transplantation. A Network... https://pubmed.ncbi.nlm.nih.gov/26425143/ Clinical experience with everolimus in the second-line treatment of advanced renal cell carcinoma Everolimus is an oral inhibitor of mammalian target of rapamycin (mTOR-I) and is currently approved for the treatment of metastatic renal cell carcinoma (mRCC)... https://adisinsight.springer.com/drugsafety/803923677?error=cookies_not_supported&code=7293abe4-e0ec-417f-90dd-28c72a752aea Everolimus - AdisInsight An 81-year-old woman with a history of hypertension, chronic kidney disease, aortic stenosis and pancreatic neuroendocrine tumour with metastatic liver disease everolimus adisinsight https://pubmed.ncbi.nlm.nih.gov/24009623/ Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a... The mammalian target of rapamycin (mTOR) inhibitors, a set of promising potential anti-cancer agents, has shown response variability among individuals. This... https://pubmed.ncbi.nlm.nih.gov/32753993/ Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient... Neuroendocrine tumors (NETs) of the lung are well-differentiated neuroendocrine neoplasms (NENs) with a heterogeneous clinical behaviour. Unlike... clinical evaluation the treatment neuroendocrine tumors everolimus https://pubmed.ncbi.nlm.nih.gov/29081664/ Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4 These results suggest that everolimus improves PFS in patients with advanced, progressive lung or GI NET, regardless of prior therapies. Safety findings were... https://www.nice.org.uk/guidance/ta421/ifp/chapter/What-has-NICE-said What has NICE said? | Information for the public | Everolimus with exemestane for treating advanced... Evidence-based recommendations on everolimus (Afinitor) for treating advanced breast cancer in adults after endocrine therapy information for the public https://research.utwente.nl/en/publications/women-treated-with-second-generation-zotarolimus-eluting-resolute/ Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting... second generation women treated https://pubmed.ncbi.nlm.nih.gov/22736724/ Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors Octreotide and everolimus have demonstrated efficacy in neuroendocrine tumors. Pasireotide is a somatostatin analog with binding affinity to a broader range of... phase i study https://adisinsight.springer.com/drugsafety/803143693?error=cookies_not_supported&code=3c26445f-b1dc-43b2-8ae6-aebd54c3ff8c Everolimus - AdisInsight A woman in her 20's [specific onset age not stated] developed mucositis, increased serum cholesterol level and liver toxicity during treatment with everolimus everolimus adisinsight https://www.nice.org.uk/guidance/ta421/chapter/6-Appraisal-committee-members-and-NICE-project-team 6 Appraisal committee members and NICE project team | Everolimus with exemestane for treating... Evidence-based recommendations on everolimus (Afinitor) for treating advanced breast cancer in adults after endocrine therapy https://www.mdpi.com/2077-0383/8/2/232 Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential... Tuberculosis (TB) is a serious infectious disease caused by the pathogen Mycobacterium tuberculosis (Mtb). The current therapy consists of a combination of... https://adisinsight.springer.com/drugsafety/803929629?error=cookies_not_supported&code=5d4b6798-8056-4ca6-b554-4a5da8bd1d8d Everolimus - AdisInsight A 64-year-old man who had undergone left single-lung transplantation in March 2023 experienced severe hypertriglyceridaemia while receiving the mTOR inhibitor everolimus adisinsight https://adisinsight.springer.com/drugsafety/803005884?error=cookies_not_supported&code=f87361c1-1335-4313-80d9-021daed3941c Everolimus - AdisInsight A 63-year-old female liver transplant recipient developed pneumonitis after receiving everolimus for immunosuppression while participating in the RESCUE everolimus adisinsight https://adisinsight.springer.com/drugsafety/803113292?error=cookies_not_supported&code=a450b08e-3530-4c47-8190-bfd28db091ac Everolimus - AdisInsight A female infant developed hypokalaemia during treatment with everolimus.The girl was born at 302/7weeks. Her mother had a history of tuberous sclerosis complex. everolimus adisinsight https://pubmed.ncbi.nlm.nih.gov/28547856/ Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with... The aim of this work is to assess if cumulative dose (CD) and dose intensity (DI) of everolimus may affect survival of advanced pancreatic neuroendocrine... prognostic impact of the https://adisinsight.springer.com/trials/700241851?error=cookies_not_supported&code=db394b49-0133-4490-9f75-f5fdd823a6d4 Everolimus (Afinitor) in Patients With Metastatic Renal Cell Carcinoma Following Progression on... This trial evaluated the efficacy of everolimus [Afinitor] in metastatic renal cell carcinoma patients following progression on bevacizumab (with or without renal cell carcinoma https://www.cruk.cam.ac.uk/publications/phase-i-study-of-everolimus-in-pediatric-patients-with-refractory-solid-tumors/ Phase I study of everolimus in pediatric patients with refractory solid tumors. - Cancer Research... Authors: M Fouladi, F Laningham, J Wu, MA O'Shaughnessy, K Molina, A Broniscer, SL Spunt, I Luckett, CF Stewart, PJ Houghton, RJ Gilbertson, WL Furman Journal... phase i study https://www.nice.org.uk/guidance/ta421/history History | Everolimus with exemestane for treating advanced breast cancer after endocrine therapy |... Evidence-based recommendations on everolimus (Afinitor) for treating advanced breast cancer in adults after endocrine therapy advanced breast cancer https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-gdc-0980-with-everolimus-kidney-cancer-that-has-spread-rover A trial looking at apitolisib with everolimus for kidney cancer that has spread (ROVER) This trial compared apitolisib and everolimus for kidney cancer that had spread to another part of the body. https://www.scirp.org/journal/paperinformation?paperid=52166 Successful Tacrolimus Therapy Extended by Everolimus in Retroperitoneal Angiomyolipoma after Lung... Discover a groundbreaking case of lung transplantation for end stage pulmonary LAM. Learn about the successful treatment of angiomyolipoma with combination... successful tacrolimus therapy extended https://adisinsight.springer.com/drugsafety/803319099?error=cookies_not_supported&code=31239f13-1132-4d12-9882-e2451c912a87 Everolimus/tacrolimus - AdisInsight In a retrospective case-control study of 179 patients, two patients were described [ages and sexes not stated], of whom, the first patient developed renal everolimus tacrolimus adisinsight https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-at-everolimus-for-neuroendocrine-tumours-of-the-pancreas-oblique A study looking at everolimus for neuroendocrine tumours of the pancreas (The OBLIQUE study) This study is to find out more about the drug everolimus (also known Afinitor) as a treatment for neuroendocrine tumours of the pancreas. a study looking at https://adisinsight.springer.com/drugsafety/803237801?error=cookies_not_supported&code=2761906a-3a21-4ab7-84db-7f6dae74d60c Everolimus - AdisInsight A 64-year-old man developed Mycobacterium tuberculosis (TB) during treatment with everolimus.The man with metastatic clear renal cell carcinoma started everolimus adisinsight https://www.scirp.org/journal/paperinformation?paperid=26216 Everolimus Associated with Activated Vitamin D for Post-Transplant Increase Epstein-Barr-Virus Load... Discover the potential of everolimus and calcitriol as a safe and effective treatment for preventing post-transplant lymphoproliferative disease (PTLD) in... https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1197549/full Frontiers | Population pharmacokinetics of everolimus in patients with seizures associated with... Everolimus is an inhibitor of mammalian target of rapamycin complex 1 (mTORC1). As mutations in TSC1 and TSC2 which cause partial-onset seizures associated w... in patients frontiers population pharmacokinetics everolimus https://pmc.ncbi.nlm.nih.gov/articles/PMC11853220/ Everolimus in the Treatment of Neuroendocrine Tumors: Lights and Shadows - PMC Neuroendocrine tumors (NETs) comprise a heterogeneous group of neoplasms that originate from neuroendocrine cells, characterized by their ability to secrete... lights and shadows in the neuroendocrine tumors everolimus treatment https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158476 Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the... Background Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has demonstrated efficacy in treating subependymal giant cell astrocytomas (SEGAs) and... https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT02228681&r=1 Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer - NCI Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer hormonal therapy endometrial cancer everolimus letrozole https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c7bb6ba1-9a7f-43f5-b058-ef26d4b59221 DailyMed - EVEROLIMUS- everolimus tablets tablet dailymed everolimus tablets https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-everolimus-and-sunitinib-for-advanced-kidney-cancer A trial looking at the order in which everolimus and sunitinib should be given for advanced kidney... This trial compared 2 different orders (sequences) of having everolimus and sunitinib for kidney cancer that had spread to other parts of the body. https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/00054-0482/ 00054-0482 Everolimus - CanMED: NDC CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. everolimus ndc https://scholars.uky.edu/en/projects/a-phase-ii-study-of-combined-fulvestrant-fulvestrant-and-rad001-e-5/ A Phase II Study of Combined Fulvestrant (Fulvestrant) and RAD001 (Everolimus) in... phase ii study https://publikationen.uni-tuebingen.de/xmlui/handle/10900/119240 Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma:... https://pubmed.ncbi.nlm.nih.gov/29055056/ Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors:... In the phase III RADIANT-4 study, everolimus improved median progression-free survival (PFS) by 7.1 months in patients with advanced, progressive,... everolimus advanced progressive well differentiated https://adisinsight.springer.com/trials/700197374?error=cookies_not_supported&code=1be83d3c-3dd2-4111-a706-8d3628d0fa22 A Phase I Dose Escalation Study of the mTOR Inhibitor Everolimus (RAD001) and Erlotinib... This trial will investigate the tolerability and efficacy of everolimus alone and in combination with erlotinib concurrently with radiotherapy in patients with https://www.nice.org.uk/guidance/ta421/chapter/3-Evidence 3 Evidence | Everolimus with exemestane for treating advanced breast cancer after endocrine therapy... Evidence-based recommendations on everolimus (Afinitor) for treating advanced breast cancer in adults after endocrine therapy advanced breast cancer https://scholars.duke.edu/publication/1162762 Scholars@Duke publication: Bevacizumab (B) plus everolimus (E) in refractory metastatic colorectal... b plus https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-rad001-kidney-cancer-that-has-spread-raptor A trial looking at everolimus for kidney cancer that has spread (RAPTOR) This trial looked at everolimus for papillary renal cell cancer that had spread to another part of the body. looking at https://adisinsight.springer.com/drugsafety/803427447?error=cookies_not_supported&code=598334ea-36d8-4fbb-bfa9-616183666a3e Everolimus - AdisInsight A 42-year-old woman developed acneiform rash on back while receiving everolimus for intra-abdominal recurrence of tumour and lymphangioleiomyomatosis in the everolimus adisinsight https://adisinsight.springer.com/trials/700390916?error=cookies_not_supported&code=d5cf7e0d-f5f3-45c2-85fd-8b5777ab1ca8 Everolimus in Refractory Metastatic Colorectal Cancer With CDK12 Deficiency: A Prospective... This is a prospective, open-label, multicenter, single-arm Phase Ib/II study evaluating the safety and preliminary efficacy of everolimus in patients with metastatic colorectal cancer everolimus refractory https://pubmed.ncbi.nlm.nih.gov/26406148/?dopt=Abstract Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma Among patients with previously treated advanced renal-cell carcinoma, overall survival was longer and fewer grade 3 or 4 adverse events occurred with nivolumab... nivolumab versus everolimus advanced renal https://pure.psu.edu/en/publications/renal-protective-effect-of-everolimus-in-liver-transplantation-a-/fingerprints/ Renal Protective Effect of Everolimus in Liver Transplantation: A Prospective Randomized Open-Label... https://pubmed.ncbi.nlm.nih.gov/40313040/ A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory... https://www.nice.org.uk/guidance/TA421/chapter/1-Recommendations 1 Recommendations | Everolimus with exemestane for treating advanced breast cancer after endocrine... Evidence-based recommendations on everolimus (Afinitor) for treating advanced breast cancer in adults after endocrine therapy advanced breast cancer https://open.library.emory.edu/concern/publications/520de740-71e3-494e-b259-b0f071a1a380 Phase I and pharmacokinetic study of everolimus, an mTOR inhibitor, in combination with docetaxel... Phase I and pharmacokinetic study of everolimus, an mTOR inhibitor, in combination with docetaxel for recurrent/refractory non-small cell lung cancer https://myhealth.alberta.ca/health/medications/Pages/conditions.aspx?hwid=fdb1539 Everolimus Tablet - For Oral Suspension everolimus tablet oral suspension https://www.sciencedaily.com/releases/2011/02/110209175757.htm Everolimus improves progression-free survival for patients with rare pancreatic cancer, study finds... In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve... https://researchdiscovery.drexel.edu/esploro/outputs/journalArticle/North-American-Results-from-the-Multicenter/991019168357404721?institution=01DRXU_INST&skipUsageReporting=true&recordUsage=false North American Results from the Multicenter Randomized Trial of Everolimus vs Mycophenolate Mofetil... Final 24-month (M) results of a randomized, open-label, multinational study (A2310) comparing efficacy and safety of everolimus (EVR) with mycophenolate...